Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05045547
Other study ID # HCR21005
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 17, 2022
Est. completion date December 31, 2023

Study information

Verified date March 2023
Source University of Oxford
Contact Thomas J Peto, Dr.
Phone +66802187460
Email tom@tropmedres.ac
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This project will conduct pragmatic operational research in rural communities served by approximately 12 health centres and 120 village malaria workers in Battambang/Pailin, western Cambodia. This study is funded by Global Fund/Regional Artemisinin Initiative (RAI3E). The grant reference number is QSE-M-UNOPS-MORU-20864-007-42


Description:

This is an integration of activities with the South and Southeast Asian Community-based Trials Network (SEACTN) that is ongoing in Lao PDR and Bangladesh. The SEACTN study aims to identify the most relevant ways in which village health worker roles can be expanded to include management of community febrile illness. A number of SEACTN activities will also be conducted in Cambodia alongside this project. For this project, the study team will test specific examples of expanded roles of VMWs including testing for other causes of fever in people who are malaria negative and assessing the feasibility of diagnostics other than malaria RDTs at health centres. Quantitative and qualitative data will be collected to determine acceptability, a mixed-methods approach will be used for the assessment: • Quantitative method Participants with febrile illness attending village malaria workers will be tested by novel rapid diagnostic tests (Dengue and CRP rapid test) in addition to a standard malaria test. Village malaria workers (VMWs)/ mobile malaria workers (MMWs) will be trained to conduct a package of activities ((i) hygiene and sanitation; (ii) disease surveillance; (iii) EPI and ANC support; (iv) management of mild common illnesses that they will carry out alongside their usual role of testing (RDTs) and treating malaria. If possible, within a week of conducting a novel RDT, a well-being follow up will be undertaken by the VMW, either via telephone or face-to-face. For the primary outcomes, the study team will report numbers and proportions of training modules passed, malaria tests performed, new diagnostic tests performed correctly, algorithms followed correctly, number of consultations, coverage estimates, and the study team will use the national malaria information system to provide a comparison in activity levels compared to other areas of Cambodia. The study team will record the incidence and aetiology of febrile illnesses. • Qualitative method A set of interviews/discussions with health centre staffs and local stakeholders will be conducted to refine the intervention design and implementation strategy. To this end, the interviews will elicit the views and experience of local stakeholders on (1) health care needs and gaps in local communities, (2) views and past experiences concerning the implementation of the VMW programme, with a focus on challenges and good practices around the use of RDTs, and (3) their views about suitable methods and strategies to expand the current VMW programme considering the new technologies available. Findings from the study will highlight to the wider scientific community the benefits and challenges of expanding the roles of VMW/MMWs.


Recruitment information / eligibility

Status Recruiting
Enrollment 7000
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria 1. Quantitative research - Written informed consent - Willingness to provide blood sample - Fever (=37.5 C) or history of fever within 24 hours 2. Qualitative research 2.1 Health centre-based evaluation of novel diagnostics - Health centre staff who have received training in the use of the novel diagnostics used in the study - Willing and able to give informed consent for participation in the study 2.2 Stakeholder analysis - Adults, male or female, aged 18 years and over - Willing and able to give informed consent for participation in the study Exclusion Criteria 1. Quantitative research • Participants requires urgent medical attention 2. Qualitative research - Identified with intellectual and/or cognitive disability - History of or current psychiatric illness

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Cambodia Action for Health and Development Battambang

Sponsors (2)

Lead Sponsor Collaborator
University of Oxford Mahidol Oxford Tropical Medicine Research Unit

Country where clinical trial is conducted

Cambodia, 

Outcome

Type Measure Description Time frame Safety issue
Other The number of patients appropriately referred for further care The number of patients appropriately referred for further care Approximately 18-24 months
Primary The number of VMW consultations by patients The number of VMW consultations by patients with a febrile and/or non-febrile illness along with the number of malaria RDTs used will be recorded. Comparing these data across the different intervention packages introduced for VMWs. Approximately 18-24 months
Secondary The number of VMWs that can correctly perform RDTS following a directly observed practical assessment and questionnaire. The number of VMWs that can correctly perform RDTS following a directly observed practical assessment and questionnaire. Approximately 18-24 months
Secondary The number of VMWs who correctly follow the treatment algorithms following a directly observed practical assessment and questionnaire. The number of VMWs who correctly follow the treatment algorithms following a directly observed practical assessment and questionnaire. Approximately 18-24 months
Secondary The overall consensus of stakeholders regarding the new roles of VMWs following stakeholder interviews The overall consensus of stakeholders regarding the new roles of VMWs following stakeholder interviews 0 months, mid-point of the study (12 months) and at study completion (24 months)
Secondary The overall consensus of stakeholders of the impact on non-malarial febrile illness management following stakeholder interviews The overall consensus of stakeholders of the impact on non-malarial febrile illness management following stakeholder interviews 0 months, mid-point of the study (12 months) and at study completion (24 months)
Secondary The number of VMWs that can correctly deliver one of four health intervention packages following a directly observed practical assessment and questionnaire. The number of VMWs that can correctly deliver one of four health intervention packages following a directly observed practical assessment and questionnaire. 0 months, mid-point of the study (12 months) and at study completion (24 months)
Secondary The number of health centre staff that can correctly perform RDTs following a directly observed practical assessment and questionnaire The number of health centre staff that can correctly perform RDTs following a directly observed practical assessment and questionnaire Approximately 18-24 months
Secondary The overall consensus of stakeholders on the use of novel RDTs following stakeholder interviews and focus group discussions. The overall consensus of stakeholders on the use of novel RDTs following stakeholder interviews and focus group discussions. Approximately 18-24 months
Secondary The overall consensus of stakeholders regarding these new roles following stakeholder interviews The overall consensus of stakeholders regarding these new roles following stakeholder interviews At study completion (24 months)
See also
  Status Clinical Trial Phase
Completed NCT00327964 - Rapid Diagnostic Tests (RDTs) for Malaria in Kampala, Uganda
Completed NCT04925401 - Evaluation of Knowledge About Fever After Consultation in the Pediatric Emergency Department N/A
Completed NCT03513861 - Family Assisted Severe Febrile Illness Therapy for Critically-ill Kenyan Children N/A
Recruiting NCT05850013 - The Measurement of Vital Signs in Children by Lifelight® Software in Comparison to the Standard of Care
Completed NCT03810014 - Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: the TESTsmART Trial AIM 1 N/A
Recruiting NCT06122259 - Febrile Illness in Guinea
Withdrawn NCT05640310 - Prospective Study to Validate the Clinical Accuracy of Norbert Device to Measure Body Temperature
Not yet recruiting NCT01288846 - Medication List in and Out of Hospital N/A
Completed NCT04428385 - Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: TESTsmART Aim 2 - Nigeria N/A
Completed NCT01735084 - Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life Phase 4
Active, not recruiting NCT04760678 - Febrile Illness in Kinshasa and Kimpese
Completed NCT02903342 - Fever and Febrile Support for Parents and Carers of Children 2016 N/A
Recruiting NCT05441800 - Epidemiology and Clinical Characteristics of Emerging and Re-emerging Infectious Diseases With Epidemic Potential in Mali
Completed NCT00146796 - A Randomised Trial of Rapid Diagnostic Tests in the Diagnosis of Malaria in Tanzania Phase 4
Completed NCT04428307 - Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: TESTsmART Aim 2 - Kenya N/A
Completed NCT05721131 - NC Thermometer (Gen 3) ISO 80601-2-56 Validation
Enrolling by invitation NCT06056011 - Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018 N/A
Completed NCT04289688 - Health Itinerary of Young Children With Suspected Bloodstream Infection in Kisantu General Referral Hospital, DR Congo
Withdrawn NCT03147534 - Comparison of Thermometry in Canada for Pediatrics N/A
Not yet recruiting NCT06422338 - A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients) N/A